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Abstract
Background: Hepatitis B virus (HBV) infection is significant health problem, as it can lead to chronic hepatitis, liver
cirrhosis, and hepatic carcinoma. Due to shared routes of transmission, HBV and human immunodeficiency virus
(HIV) co-infection is common and is an emerging concern in the clinical management of patients because of
increased mortality, accelerated hepatic disease progression, and the frequent hepatotoxicity caused by anti-
retroviral therapy. The aim of this study was to determine the prevalence of Hepatitis B surface antigen (HBsAg)
and its risk factors, among individuals visiting Shashemene General Hospital VCT center.
Findings: Institution based cross-sectional study was performed from November 3, 2008 to December 29, 2008
and 384 voluntary counseling and testing (VCT) clients were investigated. Data on socio demographic and HBV risk
factors was collected using structured questionnaires. Blood samples were collected and screened for hepatitis B
surface antigen (HBsAg) and HIV by commercially available rapid test kits. The prevalence of HBsAg in this study
group was 5.7%. Fourteen percent of HIV positive subjects (8/57) and 4.3% (14/327) of HIV negative subjects were
positive for HBsAg. Significantly high prevalence of HBsAg was observed among individuals who had history of
invasive procedures, like tooth extraction, abortion and ear piercing; history of hospital admission, history of unsafe
inject and HIV positives.
Conclusions: Although HBsAg prevalence is much higher among subjects who are HIV positive (14.0% versus
4.3%), the prevalence of HBsAg in HIV negative subjects is high enough to warrant a recommendation to screen all
clients at VCT centers irrespective of HIV status.
Background
Hepatitis B virus (HBV) infection is one of the major
diseases of mankind that has shown to cause serious
public health problem. It is estimated that about 2 bil-
lion people are infected with HBV world wide; of which
more than 350 million have chronic HBV, and 1. 2 mil-
lion die from chronic hepatitis, cirrhosis and hepatocel-
lular carcinoma [1]. The global prevalence of HBV
infection varies widely; and its endemicity ranges from
high (≥8%) to intermediate (2-7%) and low (<2%) [2].
Regions like South East Asia and sub-Saharan Africa are
high endemic areas [3] for HBV. Ethiopia, being part of
this region, is ranked as an area with medium to high
endemicity for HBV infection, based on previous popu-
lation surveys [4,5].
In sub-Saharan Africa, almost all infections occur dur-
ing the prenatal period or early childhood. Unscreened
donated blood, unsafe therapeutic practices, including
the use of inadequately sterilized needles and medical
instruments [3], are the major routes of HBV transmis-
sion apart from sexual exposure in these regions. WHO
estimate indicates that in developing counties using
non-sterile, reused syringes or needles cause 12-18 mil-
lion HBV infections annually [6].
HBV and HIV share common routes of transmission.
In Ethiopia, heterosexual transmission is responsible for
most HIV infections [7]. Additionally, Ethiopia being
one of the countries most hit by HIV infection (preva-
l e n c eo f2 . 1 % )[ 8 ]a n da l s of o u n di nar e g i o nc l a s s i f i e d
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HBV/HIV co infection is highly anticipated.
The consequences of HBV co infection with HIV is far
reaching. In the United States, it is estimated that 10%
of HIV infected individuals are HBV surface antigen
positive [9] and that HIV infected individuals are 3 to 6
times more likely to develop chronic HBV infection
than HIV uninfected individuals [10]. However, in Africa
in general and in Ethiopia in particular, information on
the magnitude of HBV positivity at different risk groups
including people living with HIV/AIDS is scarce. Thus,
studies to monitor exposure proportions and associated
risk factors have paramount importance to undertake
effective prevention measures. In line with this, Counsel-
ing and Testing, is a crucial intervention component of
the HIV/AIDS prevention. Despite challenging circum-
stances, Ethiopia has dramatically increased its VCT
coverage. The number of VCT facilities increased from
23 in 2001 to more than 1000 in 2007, and the number
of HIV tests taken doubled in one year, from 1.7 million
tests in 2007 to 3.5 million in 2008 [11].
Therefore, this study was conducted among clients of
Shashemene General Hospital VCT center, to determine
the prevalence of hepatitis-B surface antigen (HBsAg),
co infection with HIV and associated risk factors.
Methods
A hospital based cross-sectional study was conducted at
Shashemene General Hospital, South Ethiopia, VCT
center from November 3, 2008 to December 29, 2008.
The VCT center at the hospital routinely gives HIV
counseling and testing for the clients. Individuals tested
positive for HIV infection were referred to anti-
retroviral therapy (ART) clinics for further clinical and
laboratory investigations and those found eligible for
ART receive highly active anti-retroviral therapy
(HAART). However, hepatitis testing was not performed
in the hospital routinely.
The study population comprises of all individuals
attending VCT center of Shashemene General Hospital
for HIV testing. Counselor nurses interviewed the
study subjects using structured questionnaire on socio-
demographic characteristics and other risk factors.
Standard procedure was used during blood sample
collection. Whole blood was used for HIV screening
tests while serum was used for HBsAg screening. The
hospital routinely uses commercial HIV test kits (KHB,
Shangha Kehua Bio-engineering Co., Ltd. China) for
screening and positive samples were re-tested with
STAT-PACK (Chembio HIV 1/2 STAT-PAK™ Assay,
CHEMBIO DIAGNOSTIC SYSTEMS, INC., MED-
FORD, NY, USA). Samples giving discordant results in
the two tests were re-examined using tie-breaker, (Uni-
Gold HIV, Trinity Biotech PLC, Co. Wicklow, Ireland).
All sera were screened for HBsAg using commercially
available HBsAg screening rapid test kit according to
the manufacturer’s instruction (TULIP DIAGNOSTICS
(P) LTD, India). The kit has a sensitivity of 87.3% and
specificity of 100% [12].
Data were analyzed using SPSS version 15 soft ware.
Proportions were used to summarize the frequency of
occurrence of target outcomes in different categories
of exposure variables. Precision of the prevalence of
HBsAg across different categories of pre-specified risk
factors was assessed by presenting 95% confidence inter-
val around the estimates. Statistical significance of dif-
ference of proportion was evaluated using Chi-square
test. P-value < 0.05 was considered as indicator for sta-
tistical significance.
The study was approved by the National Health
Research Ethics Committee and Ethical Clearance Com-
mittee of Akililu Lemma Institute of Pathobiology. Sepa-
rate permission was also obtained from Shashemene
General Hospital. The purpose of the study was
explained to the participants and written consent was
obtained before sampling. HBs Ag positive participants
were handled by the hospital physicians.
Results
During the study period 391 individuals were
approached and 384 were screened for HBsAg and HIV
sero status resulting in 98.2% response rate. Socio-
demographic characteristics of the participants are pre-
sented in Table 1. Of the total 384 VCT clients
screened, 14.8% (95%CI: 11.4%, 18.8%) clients were sero
positive for HIV and 5.7% (95%CI:3.6%, 8.5%) were posi-
tive for HBsAg. Fifty four percent of the participants
were from Shashemene town and 52.1% were males
resulting in the female to male ratio of 0.9:1. Among the
study subjects 56.3% were married and 31.0% were
never married, and 29.1% of the study subjects belonged
to 30-39 years of age.
The distribution of hepatitis B surface antigen in dif-
ferent risk factors is indicated in Table 2. Of different
risk factors considered in the study, history of having
multiple sexual partners accounted the bigger number
(34.6%; 95%CI: 29.9%, 39.6%). But the association of
HBsAg and having multiple sexual partner was not sta-
tistically significant (P = 0.86). History of having invasive
procedures (P = 0.006) and unsafe drug injection (injec-
tion of prescribed medication with unsteralized needles)
(P <0.001) were significantly associated with increased
risk of HBV carriage. Hospital admission was also signif-
icantly associated with HBsAg carriage (P = 0.015).
Other risk factors, like blood transfusion, history of
sexually transmitted infections (STIs), history of liver
disease and contact with liver diseased family were not
significantly associated with HBV carriage.
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Page 2 of 5There were 8 clients with history of STIs and all of
them were HIV positive and of 12 divorced individuals,
3 (25.0%) were HIV positive. Of total 22 HBs Ag posi-
tive individuals, 8(36.4%) were also positive for HIV and
there was significant association between HBsAg car-
riage and HIV infection (P = 0.003).
Discussion
In this hospital based cross-sectional study, a 5.7% pre-
valence of hepatitis B virus carriage among VCT clients
of Shashemene General Hospital was determined.
Similarly, a study conducted in Addis Ababa revealed a
5.7% HBsAg prevalence among VCT clients [13].
Another community based sero-epidemiological survey
that addresses the transmission dynamics and control of
hepatitis B virus in Addis Ababa, reported HBsAg preva-
lence of 7.0% from the general population [4], which is
not significantly different from the current study (P =
0.373). A 3.7% HBsAg prevalence was also reported
among pregnant women in Jimma [14].
In our study higher HBsAg positivity (14.0%) was
observed among HIV positive individuals. This is
Table 1 Socio-demographic characteristics and proportion of hepatitis B surface antigen (HBsAg) among Different
categories of study subjects at Shashemene General Hospital, 2008
Characteristics Total (%) Number (%) positive HBsAg chi-square value P value
Residence
Rural 178(46.4) 8(4.5)
Urban 206(53.6) 14(6.8) 0.937 0.333
Age
<20 79(20.5) 3(3.8)
20-29 92(24.0) 5(5.4)
30-39 112(29.2) 8(7.1) 2.923 0.570
40-49 57(14.8) 5(8.8)
≥50 44(11.5) 1(2.3)
Sex
Male 200(52.1) 15(7.7)
Female 184(47.9) 7(3.8) 2.423 0.120
Marital Status
Married 216(56.3) 14(6.5)
Single 119(31.0) 7(5.9)
Divorced 12(3.1) 0 1.588 0.662
Widowed 37 (9.6) 1(2.7)
Religion
Christian 195(50.8) 11(5.6) 0.006 0.940
Muslim 189(49.2) 11(5.8)
Ethnicity
Oromo 183(47.7) 14(7.7) 2.639 0.451
Amhara 105(27.3) 5(4.8)
Gurage 31(8.1) 1(3.2)
Wolayta 65(16.9) 2(3.1)
Occupation
Merchant 96(25.0) 8(8.3) 3.381 0.760
House wife 92(24.0) 5(5.4)
Student 44(11.5) 1(2.3)
Farmer 63(16.4) 3(4.8)
Driver 7(1.8) 1(14.3)
Gov’t Employee 18(4.7) 1(5.6)
No work 64(16.7) 3(4.7)
Educational Status
Illiterate 142(37.0) 11(7.7) 5.238 0.155
Primary school 125(32.6) 5(4.0)
Secondary school l96 (25.0) 5(5.2)
Diploma & above 21(5.5) 1(4.5)
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Page 3 of 5comparable with a study done by Burnett et al.,[ 3 ]
which documented an increased occurrence of HBV
among HIV positive individuals. This could be due to
the shared transmission route of both HBV and HIV
infection. However, a study done from VCT centers in
Addis Ababa reported no significant difference with
HBsAg carriage and HIV serostatus [13]. Another study
from the general population and from pregnant HIV
infected women in the USA also indicated a much
lower prevalence of HBV, 0.4% and 1.5%, respectively, as
compared to the present study [15]. This could be due
to the fact that in most developed parts of the world
(Western Europe, USA, Australia), the endemicity of
HBV infection is low [3].
In the present study no association has been found
between HBsAg positivity and gender unlike other stu-
dies done in the country from VCT centers and general
population, where male were found to have high HBsAg
[4,13]. Similarly no association was observed with
HBsAg positivity and other sociodemographic variables
like, illiteracy and participants income. Nonetheless, a
study done in Jimma among pregnant women has
shown high HBsAg positivity rate among the illiterate
and those with low income [14].
In agreement with other studies [2], in this study also
significantly high prevalence of HBsAg was observed
among individuals with history of invasive procedures,
like tooth extraction, abortion [14], ear piercing and
unsafe inject. In addition, participants with history of
hospital admission had significantly high HBsAg (P =
0.015). This is comparable with study done in Greece in
high-risk hospitalized patients [16]. Individuals who had
multiple sexual partners were infected with HBV at
higher rate, although the difference was not statistically
significant.
This study is not without limitations. Our findings
were based on rapid test kit which might have underes-
timated the true prevalence which could have been
obtained if we were able to use radioimmunoassay anti-
gen test or enzyme linked immunosorbent assay. Addi-
tionally, because of the small number of HBsAg
positivity among study participants with history of
known risk factors, we were not able to report the
adjusted effects of these factors on the prevalence of
HBsAg. This coupled with wide confidence interval of
unadjusted effects suggest the importance of further
study to establish the strength of the reported associa-
tions with these risk factors.
In conclusion high proportion of HBsAg was deter-
mined in this study. This indicates the importance of
implementing preventive measures, including vaccina-
tion, to the health care workers at the VCT sites, as
they are reported to be at increased risk of acquiring
HBV compared to the general population [17].
Table 2 Distribution of Hepatitis B virus (HBsAg) in subjects with different risk factors at Shashemene General
Hospital, 2008
Characteristics Total (%) Number (%) positive HBsAg 95% CI for HBsAg prevalence chi-square value P value
HBV vaccination
Non vaccinated 377(98.2) 21(5.6) 3.5, 8.3 0.967 0.336
Vaccinated 7(1.8) 1(14.3) 0.3, 57.9
History of Hospital admission
No 369(96.1) 19(5.2) 3.1, 7.9 5.886 0.015
Yes 15(3.9) 3(20.0) 4.3, 48.1
Unsafe inject
No 370(96.4) 18(4.9) 2.9, 7.6
Yes 14(3.6) 4(28.6) 8.4, 58.1 14.0368 <0.001
Multiple sexual partner
No 251(65.4) 14(5.6) 3.1,9.2
Yes 133(34.6) 8(6.0) 2.6,11.5 0.031 0.860
STIs
No 376 (97.9) 21(5.6) 3.5,8.4
Yes 8(2.1) 1(12.5) 0.3, 52.7 0.694 0.405
Invasive procedure*
No 335 (87.2) 15(4.5) 2.5,7.3
Yes 49 (12.8) 7 (14.3) 5.9,27.2 7.61 0.006
HIV status
No 327(85.2) 14(4.3) 2.4,7.1
Yes 57 (14.8) 8(14.0) 6.3,25.8 8.55 0.003
* abortion, tooth extraction, ear piercing, and tattooing.
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Page 4 of 5In addition, the authors would also like to recommend
the execution of routine HBV screening program at the
hospitals VCT centers, especially for clients found posi-
tive of HIV antibody, by so doing HBV carriers could be
identified early and managed appropriately. Moreover,
awareness creation through health education about HBV
transmission and prevention, including efforts to ensure
all injections be administered with sterile syringes and
needles is critical.
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